Jubilant Organosys, a Noida-based pharmaceutical and largest custom research and manufacturing services company, has suffered heavy setback during the third quarter ended December 2008 on account of foreign exchange loss of Rs 131.37 crore as compared to gain of Rs 13.34 in the last period and higher interest burden. The company's consolidated net loss touched to Rs 87.57 crore as against the net profit of Rs 89.44 crore in the corresponding period of last year. The profit before exceptional items and taxation declined by 21.3 per cent to Rs 80.50 crore from Rs 102.25 crore in the similar period of last year.
The details can be read here.
No comments:
Post a Comment